LUPIN LTD. - 500257 - U.S. FDA Inspection Of The Company'S Aurangabad Facility.

Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer

2072.9000 1.50 (0.07%)

NSE May 15, 2025 15:31 PM

38.81% Gain from 52W Low

Volume: 2.3M

Lupin Ltd.

15 Mar 2024, 05:32PM

2072.90

0.07%

Company Update

LUPIN LTD. - 500257 - U.S. FDA Inspection Of The Company'S Aurangabad Facility.

BSE India

U.S. FDA Inspection of the Company''s Aurangabad Facility.

More from Lupin Ltd.

Recommended

Market closes higher, Saregama India's Q4 net profit grows 11.8% YoY to Rs 60.1 crore

Trendlyne Marketwatch | 15 May 2025, 04:06PM

A car running on flat tires: Pakistan's economy is struggling

The Baseline | 15 May 2025, 09:48AM

Lupin expects normalization by September quarter